Navigation Links
Study examines risk factors for cancer in unaffected breast of breast cancer patients
Date:1/26/2009

A new study identifies certain patient and tumor characteristics that may help indicate which breast cancer patients would be the most likely to benefit from preventive surgery to remove the unaffected breast. Published in the March 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study could help patients with breast cancer make more informed treatment choices.

Women diagnosed with breast cancer are known to be at increased risk of developing breast cancer in the opposite breast, either at the time of diagnosis or some time in the future. Identifying which women are most at risk of cancer in the other breast could help patients decide whether to have preventive treatment, including mastectomy to remove the unaffected breast. While a fairly drastic measure, some women may choose this option due to a variety of factors, such as advice from their physician, fear of another breast cancer diagnosis, desire for cosmetic symmetry and family history of breast or other cancers.

While most breast cancer patients would not experience any survival benefit from such a contralateral prophylactic mastectomy, it is difficult to determine which patients should consider the procedure. If physicians could predict which patients are at the highest risk of developing contralateral breast cancer and which are not, many patients could preserve their unaffected breast if desired.

To identify the factors that predict contralateral breast cancer, Dr. Kelly K. Hunt and colleagues at the University of Texas M. D. Anderson Cancer Center in Houston studied 542 patients who had breast cancer in one breast and who had both breasts removed between 2000 and 2007.

From the prophylactic mastectomy specimen, the researchers found that twenty-five patients (5 percent) had contralateral breast cancer, and 82 patients (15 percent) had cells in the other breast that were abnormal and could signify higher risk for breast cancer development.

When the investigators looked for clinical features associated with contralateral breast cancer, they found three independent factors: when the cancer cells had certain histologic invasive characteristics; when the cancer was present in more than one quadrant of the breast; and when the patient had a 5-year Gail risk of 1.67 percent or greater. The Gail model is a breast cancer risk assessment tool used for women without a cancer diagnosis that takes into consideration a woman's medical history, age, race and other characteristics.

Also, women aged 50 years or older at the initial cancer diagnosis or who had additional moderate- to high-risk cells in their affected breast were likely to have abnormal cells in the other breast that could potentially develop into cancer.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Rob Lowe ... An upcoming production of the series is on hiking in American. Viewers can reconnect ... of the great benefits of hiking. , Many consumers have looked for an inventive ...
(Date:5/26/2017)... ... 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the stories of ... is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist and a ... when she was three. At six, they moved to Dayton, Ohio, where Penny graduated ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, ... in New York City. He is known for his distinguished expertise and experience in ... Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . ...
(Date:5/24/2017)... OH (PRWEB) , ... May 24, 2017 , ... Patients ... in Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, with ... while simultaneously improving their oral health and functionality. , Dr. Bedich offers ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: